Ophthalmologic Manifestations of Acute Leukemia Are Heterogeneous

Medically reviewed by Carmen Pope, BPharm. Last updated on July 17, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, July 17, 2024 -- Ophthalmologic manifestations of acute leukemia are heterogeneous and detectable at initial presentation or relapse, according to a study published online July 10 in the Annals of Hematology.

Dina N. Laimon, M.D., from Mansoura University in Egypt, and colleagues examined the incidence of different ophthalmological manifestations in newly diagnosed acute leukemia in a cross-sectional study involving 222 newly diagnosed acute myeloid and acute lymphoblastic leukemia patients (144 and 78, respectively) who presented between January 2022 and February 2023. All patients underwent a complete ophthalmic evaluation.

The researchers found that ophthalmic manifestations were detected in 43.2 percent of patients. Of these, 1.8 percent had poor visual acuity. The most common ocular manifestations were retinal hemorrhage and Roth spots (19.8 and 17.1 percent, respectively). Other ophthalmological manifestations included orbital involvement, ocular motility issues, subconjunctival hemorrhage, conjunctival chemosis, and lid swelling (3.2, 1.4, 5.9, 0.9, and 4.1 percent, respectively). Compared with acute lymphoblastic leukemia patients, acute myeloid leukemia patients had a significantly higher frequency of ocular affection, retinal hemorrhages, and Roth spots. A significant association was seen for retinal hemorrhage with anemia.

"Cooperation between ophthalmologists and hemato-oncologists is crucial for recognizing ocular involvement and disease management," the authors write. "We need further evaluation of a larger cohort of acute leukemia patients especially for survival analysis to set the record for the prognostic value of ocular manifestations in such neoplasms."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords